Sage Mountain Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,745
Closed -$156K 390
2022
Q3
$156K Sell
15,745
-76,944
-83% -$758K 0.04% 187
2022
Q2
$906K Sell
92,689
-71,153
-43% -$697K 0.16% 103
2022
Q1
$1.6M Sell
163,842
-11,973
-7% -$116K 0.25% 53
2021
Q4
$1.7M Sell
175,815
-3,351
-2% -$32.6K 0.2% 67
2021
Q3
$1.75M Buy
179,166
+8,330
+5% +$80.2K 0.25% 60
2021
Q2
$1.65M Buy
+170,836
New +$1.67M 0.27% 58

Other funds holding MSAC

Sage Mountain Advisors's MSAC Position: Q4 2022 in Review

Sage Mountain Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q4 2022, closing a stake of 15,745 shares — an estimated $156K sold.

Sage Mountain Advisors first reported a position in MSAC in Q2 2021 and held it in 6 quarters. The position peaked at $1.75M in Q3 2021. 49 funds tracked by Wall St. Rank hold MSAC as of Q4 2022.

  • Sage Mountain Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
  • Sage Mountain Advisors sold 15,745 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $156K.
  • Sage Mountain Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 6 quarters.
  • Sage Mountain Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.75M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q4 2022.

Based on Sage Mountain Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.